The ERA-EDTA Research Programme was created to contribute to the establishment of high level European networks of Research including TRANSLATIONAL RESEARCH PROJECTS and CLINICAL RESEARCH PROJECTS.
From 2009 to 2014, 7 Projects were granted:
Vitamin K1 to slow vascular calcification in hemodialysis patients.
The Cardiovascular Morbidity in Children with Chronic Kidney Disease.
EUROPEAN VALIDATION STUDY OF THE OXFORD CLASSIFICATION OF IGA NEPHROPATHY.
Multicenter And Open Label controlled randomised trial to evaluate the efficacy of sequential treatment with tacrolimus-rituximab versus steroids plus cyclophosphamide in patients with primary membranous nephropathy.
LUNG WATER by Ultra-Sound GUIDED TREATMENT TO PREVENT DEATH AND CARDIOVASCULAR COMPLICATIONS IN HIGH RISK END STAGE RENAL DISEASE (ESRD) PATIENTS WITH CARDIOMYOPATHY.
The EuroCYST Initiative
The EuroCYST Initiative: Building a reference centre network across EUROpe to establish a large scale longitudinal observational cohort of polyCYSTic kidney disease patients.
Let’s find out why some Alport patients do better than others.
LINKS AND ATTACHMENTS
ERA-EDTA Operative Headquarters
Via XXIV Maggio 38
43123 Parma – Italy
Phone: +39 0521 989078
Fax: +39 0521 959242
ERA-EDTA Registered Office
c/o PKF Littlejohn, 2nd Floor, 1 Westferry Circus, Canary Wharf
London E14 4HD – United Kingdom